Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A relativity concept in mesenchymal stromal cell manufacturing.
Martin I, De Boer J, Sensebe L; MSC Committee of the International Society for Cellular Therapy. Martin I, et al. Cytotherapy. 2016 May;18(5):613-20. doi: 10.1016/j.jcyt.2016.02.004. Cytotherapy. 2016. PMID: 27059199 Free article. Review.
Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study.
Stella F, Pennisi M, Chiappella A, Casadei B, Bramanti S, Ljevar S, Chiusolo P, Rocco AD, Tisi MC, Angelillo P, Cutini I, Martino M, Barone A, Bonifazi F, Santoro A, Sorà F, Novo M, Barbui AM, Russo D, Musso M, Grillo G, Krampera M, Olivieri J, Brunello L, Cavallo F, Massaia M, Arcaini L, Farina L, Zinzani P, Miceli R, Corradini P. Stella F, et al. Among authors: krampera m. Transplant Cell Ther. 2025 Jan 25:S2666-6367(25)00916-9. doi: 10.1016/j.jtct.2025.01.888. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39870308 Free article.
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation.
Perutelli F, Boccellato E, Montalbano MC, Catania G, Deodato M, Frustaci AM, Innocenti I, Moia R, Quaglia FM, Quaresmini G, Rivela P, Gaidano G, Krampera M, Laurenti L, Rambaldi A, Bruno B, Vitale C, Coscia M. Perutelli F, et al. Among authors: krampera m. Br J Haematol. 2025 Jan 7. doi: 10.1111/bjh.19976. Online ahead of print. Br J Haematol. 2025. PMID: 39777647
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.
Stella F, Chiappella A, Magni M, Bonifazi F, De Philippis C, Musso M, Cutini I, Ljevar S, Barbui AM, Farina M, Martino M, Massaia M, Grillo G, Angelillo P, Botto B, Patriarca F, Krampera M, Arcaini L, Tisi MC, Zinzani P, Sorà F, Bramanti S, Pennisi M, Carniti C, Corradini P. Stella F, et al. Among authors: krampera m. Br J Haematol. 2024 Dec 22. doi: 10.1111/bjh.19961. Online ahead of print. Br J Haematol. 2024. PMID: 39710966
Efficacy of Midostaurin Combined With Intensive Chemotherapy in Core Binding Factor Leukemia: A Phase II Clinical Trial.
Cairoli R, Gatti A, Grillo G, Stefanucci MR, Di Camillo B, Fumagalli M, Krampera M, Nadali G, Zappasodi P, Borlenghi E, Todisco E, Ubezio M, Bernardi M, Molteni A, Basilico C, Turrini M, Greco R, Mancini V, Riva M, Bernasconi DP, Brando B, Veronese SM, Beghini A. Cairoli R, et al. Among authors: krampera m. Am J Hematol. 2025 Feb;100(2):346-349. doi: 10.1002/ajh.27547. Epub 2024 Dec 10. Am J Hematol. 2025. PMID: 39659145 Clinical Trial.
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia.
Galasso M, Salaorni V, Moia R, Mozzo V, Lovato E, Cosentino C, Perbellini O, Gambino S, Lovato O, Carazzolo ME, Ferrarini I, Quaglia FM, Donadelli M, Romanelli MG, Visco C, Krampera M, Gaidano G, Scupoli MT. Galasso M, et al. Among authors: krampera m. Hematol Oncol. 2024 Nov;42(6):e70002. doi: 10.1002/hon.70002. Hematol Oncol. 2024. PMID: 39540258 Free PMC article.
Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy.
Mosna F, Borlenghi E, Litzow M, Byrd JC, Papayannidis C, Tecchio C, Ferrara F, Marcucci G, Cairoli R, Morgan EA, Gurrieri C, Yeung CCS, Deeg HJ, Capelli D, Candoni A, Gotlib JR, Lunghi M, Pullarkat S, Lanza F, Galimberti S, Forghieri F, Venditti A, Festuccia M, Audisio E, Marvalle D, Rigolin GM, Roti G, DiBona E, Visani G, Albano F, Eisfeld AK, Valent P, Huls G, Borthakur G, Krampera M, Martinelli G, Kröger N, Sperotto A, Gottardi M. Mosna F, et al. Among authors: krampera m. Haematologica. 2024 Oct 10. doi: 10.3324/haematol.2024.285448. Online ahead of print. Haematologica. 2024. PMID: 39385741 Free article.
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.
Tamellini E, Sorio M, Andreini A, Tecchio C, Nadali G, Bernardelli A, Ferrarini I, Crosera L, Vatteroni A, Simio C, Benedetti F, Krampera M, Tanasi I. Tamellini E, et al. Among authors: krampera m. Blood Cell Ther. 2024 Jun 14;7(3):75-78. doi: 10.31547/bct-2024-005. eCollection 2024 Aug 25. Blood Cell Ther. 2024. PMID: 39263622 Free PMC article.
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach.
Caminati M, Carpagnano LF, Alberti C, Amaddeo F, Bixio R, Caldart F, De Franceschi L, Del Giglio M, Festi G, Friso S, Frulloni L, Gisondi P, Krampera M, Lippi G, Micheletto C, Piacentini G, Pinter P, Rossini M, Schiappoli M, Tecchio C, Tenero L, Tinazzi E, Senna G, Carlucci M; Multidisciplinary Group on rare dysimmune conditions with hyper-Eosinophilia (GEos). Caminati M, et al. Among authors: krampera m. World Allergy Organ J. 2024 Jul 25;17(8):100928. doi: 10.1016/j.waojou.2024.100928. eCollection 2024 Aug. World Allergy Organ J. 2024. PMID: 39156600 Free PMC article. Review.
211 results